Total Funding
15
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
679039
Nfocus Neuromedical develops endovascular neurosurgery solutions for the treatment of intracranial aneurysms.
Acquired by 
Covidien
Carrie Neuberger: Vice President of Quality- Eric P. Milledge: CEO & Chairman
About the Company
Nfocus Neuromedical, designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company
was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical operates as a subsidiary of Covidien plc.
